Patent ID: 8987199
Filing Date: 2015-03-24
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition for intranasal administration consisting of: insulin present in an amount from about 400 IU/mL to about 600 IU/mL; dimethyl sulfoxide present in an amount from about 24% (v/v) to about 36% (v/v); polyethylene glycol present in an amount from about 1.6% (v/v) to about 2.4% (v/v); glycerin present in an amount from about 1.2% (v/v) to about 1.8% (v/v); phenol present in an amount from about 0.05% (v/v) to about 0.15% (v/v); and water in a quantity sufficient to reach final volume.